Coverage, Cost-Control Mechanisms, and Financial Risk-Sharing Alternatives of High-Cost Health Care Technologies
for California Institute for Regenerative Medicine byBrent D. Fulton, Ph.D.
Mistique C. Felton, MPHCandy Pareja, B.A.Adam PotischmanRichard M. Scheffler, Ph.D. Nicholas C. Petris Center on Health Care Markets and Consumer WelfareSchool of Public HealthUniversity of California, BerkeleyOctober 8, 2009This report was funded by the California Institute for Regenerative Medicine (CIRM).The authors thank the individuals who participated in interviews for this report, which benefitted from their valuable information and breadth of knowledge. The authors aregrateful for the insightful comments received on an earlier draft of this report from JamesC. Robinson, Kaiser Permanente Professor of Health Economics and Director of theBerkeley Center for Health Technology, University of California-Berkeley; Bruce Quinn,MD, Senior Health Policy Specialist, Foley Hoag LLP; and CIRM. The authors thank Stephen Robitaille, Senior Editor, Petris Center, for his thoughtful editing of the report.The content of this report reflects the authors’ research and may not reflect the views of CIRM, Petris Center, the interviewees, or the reviewers.*Corresponding author: Petris Center, School of Public Health, 50 University HallMC7360, Berkeley, California 94720, email@example.com